Literature DB >> 24740275

Update on medical management of Peyronie's disease.

Ronny B W Tan1, Premsant Sangkum, Gregory C Mitchell, Wayne J G Hellstrom.   

Abstract

The treatment of Peyronie's disease (PD) is a challenge for the clinician. In the quest to straighten the penis, alleviate pain, prevent further shortening, and restore erectile function, many non-surgical treatments have been offered in lieu of an operative approach, which is still considered the gold standard for definitive treatment. This communication is an update on the different approaches used in the minimally invasive management of this frustrating and yet intriguing condition.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24740275     DOI： 10.1007/s11934-014-0415-4

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN： 1527-2737            Impact factor:   3.092


  84 in total

1.  Tissue engineering for penile surgery: comparative study of noncellular and cell-seeded synthetic grafts for tunica albuginea replacement.

Authors:  Ludovic Ferretti; Massimo Giuliani; Thomas Bessède; Xuefeng Qiu; Haiyang Zhang; Bayan Alsaid; Antoine Durrbach; François Giuliano; Gérard Benoit; Stéphane Droupy
Journal:  J Sex Med       Date:  2011-12-06       Impact factor: 3.802

2.  Peyronie's disease; cortisone-hyaluronidase-hydrocortisone therapy.

Authors:  H BODNER; A H HOWARD; J H KAPLAN
Journal:  Trans West Sect Am Urol Assoc       Date:  1953

Review 3.  Diagnostic and therapeutic applications of iontophoresis.

Authors:  Anke Sieg; Valentine Wascotte
Journal:  J Drug Target       Date:  2009-11       Impact factor: 5.121

Review 4.  Allogeneic and xenogeneic transplantation of adipose-derived stem cells in immunocompetent recipients without immunosuppressants.

Authors:  Ching-Shwun Lin; Guiting Lin; Tom F Lue
Journal:  Stem Cells Dev       Date:  2012-07-03       Impact factor: 3.272

5.  Nicardipine vs. saline injection as treatment for Peyronie's disease: a prospective, randomized, single-blind trial.

Authors:  Jintetsu Soh; Akihiro Kawauchi; Noriyuki Kanemitsu; Yoshio Naya; Atsushi Ochiai; Yasuyuki Naitoh; Terufumi Fujiwara; Kazumi Kamoi; Tsuneharu Miki
Journal:  J Sex Med       Date:  2010-11       Impact factor: 3.802

6.  A rat model of Peyronie's disease associated with a decrease in erectile activity and an increase in inducible nitric oxide synthase protein expression.

Authors:  T J Bivalacqua; E K Diner; T E Novak; Y Vohra; S C Sikka; H C Champion; P J Kadowitz; W J Hellstrom
Journal:  J Urol       Date:  2000-06       Impact factor: 7.450

7.  Summary of the recommendations on sexual dysfunctions in men.

Authors:  Tom F Lue; François Giuliano; Francesco Montorsi; Raymond C Rosen; Karl-Erik Andersson; Stanley Althof; George Christ; Dimitrios Hatzichristou; Mark Hirsch; Yasasuke Kimoto; Ronald Lewis; Kevin McKenna; Chris MacMahon; Alvaro Morales; John Mulcahy; Harin Padma-Nathan; John Pryor; Inigo Saenz de Tejada; Ridwan Shabsigh; Gorm Wagner
Journal:  J Sex Med       Date:  2004-07       Impact factor: 3.802

Review 8.  Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies.

Authors:  Martin Gelbard; Irwin Goldstein; Wayne J G Hellstrom; Chris G McMahon; Ted Smith; James Tursi; Nigel Jones; Gregory J Kaufman; Culley C Carson
Journal:  J Urol       Date:  2013-01-31       Impact factor: 7.450

9.  Topical verapamil HCl, topical trifluoperazine, and topical magnesium sulfate for the treatment of Peyronie's disease--a placebo-controlled pilot study.

Authors:  William P Fitch; W Jerry Easterling; Robert L Talbert; Michael J Bordovsky; Michael Mosier
Journal:  J Sex Med       Date:  2007-03       Impact factor: 3.802

Review 10.  Medical management of Peyronie's disease.

Authors:  Wayne J G Hellstrom
Journal:  J Androl       Date:  2008-10-30
View more
  6 in total

Review 1.  2013-2014 updates in Peyronie's disease management.

Authors:  Benjamin A Sherer; Krishnan Warrior; Laurence A Levine
Journal:  Curr Urol Rep       Date:  2014-12       Impact factor: 3.092

Review 2.  Collagenase Clostridium histolyticum in the management of Peyronie's disease: a review of the evidence.

Authors:  Elizabeth J Traore; William Wang; Faysal A Yafi; Wayne J G Hellstrom
Journal:  Ther Adv Urol       Date:  2016-03-22

3.  Collagenase clostridium hystolyticum in the management of Peyronie's disease.

Authors:  Sun Tae Ahn; Du Geon Moon
Journal:  Transl Androl Urol       Date:  2017-04

Review 4.  Penile traction therapy for Peyronie's disease-what's the evidence?

Authors:  Mustafa Faruk Usta; Tumay Ipekci
Journal:  Transl Androl Urol       Date:  2016-06

5.  Use of a lyophilized bovine pericardium graft to repair tunical defect in patients with Peyronie's disease: experience in a clinical setting.

Authors:  Javier Romero Otero; Borja García Gómez; Jose Medina Polo; Carlos Pascual Mateo; Silvia García Barreras; Eduard García Cruz; Javier de la Riva de la Viña; Alfredo Rodríguez Antolín
Journal:  Asian J Androl       Date:  2017 May-Jun       Impact factor: 3.285

6.  Scrotal septum detachment during penile plication to compensate for loss of penile length compared with conventional surgical technique.

Authors:  Sun Tae Ahn; Dong Hyun Lee; Hyeong Guk Jeong; Jong Wook Kim; Du Geon Moon
Journal:  Investig Clin Urol       Date:  2020-02-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.